secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rein Therapeutics, Inc. (RNTX)
CIK:        0001420565
Form:       8-K
Filed at:   2026-07-21T20:10:17+00:00
Accession:  0001193125-26-310315
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Rein Therapeutics stockholders approve increase in authorized shares to 200M, re-elect directors
--------------------------------------------------------------------------------

- Elected Josef H. von Rickenbach and Reinhard J. Ambros as Class III directors.
- Approved amendment to increase authorized common shares from 100M to 200M (61.0M for, 2.4M against).
- Ratified CBIZ CPAs P.C. as independent auditor for FY2026 (62.95M for, 0.17M against).
- Advisory say-on-pay approved with 37.6M for, 0.9M against, 25.1M broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420565/000119312526310315/0001193125-26-310315-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420565/000119312526310315/d89210d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-310315

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer